Paul Ko Ferrigno
CEO, éclateral
éclateral delivers clinical-grade diagnostic testing at home, enabling care providers, patients and clinicians to make faster, data-driven decisions—improving use of anti-inflammatories, antibiotics and steroids and preventing avoidable hospital admissions.
Events Paul Ko Ferrigno has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026